Exclusive distribution agreement with Spinco Biotech provides customers with improved access to life sciences product range 

GE Healthcare, a unit of General Electric Company (NYSE: GE), expands its life sciences footprint in India with an exclusive distribution agreement with Spinco Biotech, a leading distributor of analytical and life science instruments, reagents and chemicals.

GE Healthcare will also continue as a direct distributor in India for its flagship bioprocessing and drug discovery product ranges such as ÄKTA™, Biacore™ and IN Cell, as well as offering technical and service support to all customers.

The life sciences division of GE Healthcare delivers breakthroughs in drug discovery, biopharmaceutical research and manufacturing and the latest in cellular technologies so scientists and specialists can discover news ways to predict, diagnose and treat diseases earlier. The business also makes systems and equipment for the purification of biopharmaceuticals.  GE Healthcare’s life sciences business has been steadily increasing its footprint in India with the setting up a R&D center, Fast Trak™ BioPharma Services and an education center in Bangalore.

“We are confident that this new distribution relationship with Spinco will only further strengthen our capabilities to provide better solutions for the life science research community and support to our customers,” said Mr. Anurag Gupta, Managing Director Life Sciences, GE Healthcare India.

Mr. S. Thyagarajan, Chairman, Spinco Group of companies, India said: “This is a defining moment in the history of Spinco and the Indian life sciences industry. The addition of product ranges from GE Healthcare is in line with our commitment of offering total solutions to customers.”

Spinco Biotech has a proven track record of 28 years in serving the scientific community with a network of 26 offices and 300 plus Spinco sites across India and is considered one of the market leaders in life sciences product lines. Spinco is well known for its strong commitment to customer support.

Anurag Gupta, Country Manager of GE Healthcare Life Sciences, India stated: "Spinco adds a very important and complementary channel to our existing customer base in India. The presence Spinco has in the life sciences research and academic sector will increase our coverage and efficiency with customers across India.  We look forward to working with Spinco to make this deal a great success."

GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat, and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection, and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17- billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our Web site at www.gehealthcare.com.

Spinco Biotech Pvt Ltd.
As a leading distributor of Analytical and Life Science Instrumentation we are committed to excellence in every function of our business - using people, knowledge, innovation and technology to provide our customers with products of the highest quality and world class services. Our endeavor has always been to delight customers in whatever we do.  Our Business Philosophy has been driven by the passion for excellence, and people focus. We rededicate ourselves in our mission to serve our customers with superior products and be a part of their success stories.

Spinco Biotech is the distributor for Shimadzu HPLC over 25 years particularly for HPLC.  They are also exclusively distributing  Affymetrix Inc., USA; Molecular Devices Corporation - now part of MDS Analytical Technologies, USA;  in India. For more information about Spinco Biotech, visit www.spincotech.com

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Wall Street opens flat after rally - Iran to pay rupee for India imports in two weeks - Opelina Finance ups stake in JSPL to 8.42% - LIC appoints Sushobhan Sarker as managing director - Corporates love for PEs to continue as IPOs dry up: survey

Read Business news in  Advertisements